PLoS ONE (Jan 2012)

Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression.

  • Wan-Li Cheng,
  • Ming-Ming Tsai,
  • Chung-Ying Tsai,
  • Ya-Hui Huang,
  • Cheng-Yi Chen,
  • Hsiang-Cheng Chi,
  • Yi-Hsin Tseng,
  • Im-Wai Chao,
  • Wei-Chi Lin,
  • Sheng-Ming Wu,
  • Ying Liang,
  • Chia-Jung Liao,
  • Yang-Hsiang Lin,
  • I-Hsiao Chung,
  • Wei-Jan Chen,
  • Paul Y Lin,
  • Chia-Siu Wang,
  • Kwang-Huei Lin

DOI
https://doi.org/10.1371/journal.pone.0034352
Journal volume & issue
Vol. 7, no. 3
p. e34352

Abstract

Read online

Glyoxalase I (GLO1), a methylglyoxal detoxification enzyme, is implicated in the progression of human malignancies. The role of GLO1 in gastric cancer development or progression is currently unclear. The expression of GLO1 was determined in primary gastric cancer specimens using quantitative polymerase chain reaction, immunohistochemistry (IHC), and western blotting analyses. GLO1 expression was higher in gastric cancer tissues, compared with that in adjacent noncancerous tissues. Elevated expression of GLO1 was significantly associated with gastric wall invasion, lymph node metastasis, and pathological stage, suggesting a novel role of GLO1 in gastric cancer development and progression. The 5-year survival rate of the lower GLO1 expression groups was significantly greater than that of the higher expression groups (log rank P = 0.0373) in IHC experiments. Over-expression of GLO1 in gastric cancer cell lines increases cell proliferation, migration and invasiveness. Conversely, down-regulation of GLO1 with shRNA led to a marked reduction in the migration and invasion abilities. Our data strongly suggest that high expression of GLO1 in gastric cancer enhances the metastasis ability of tumor cells in vitro and in vivo, and support its efficacy as a potential marker for the detection and prognosis of gastric cancer.